Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo - Wikidata - wikimedia - TriplyDB

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

http://www.wikidata.org/entity/Q37996192

about

HIV-1 prophylactic vaccines: state of the art Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Middle East respiratory syndrome: obstacles and prospects for vaccine development DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques Developments in HIV-1 immunotherapy and therapeutic vaccination.DNAVaxDB: the first web-based DNA vaccine database and its data analysis.Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines.DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques.A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques HIV DNA Vaccine: Stepwise Improvements Make a Difference.Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45 Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunity DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles.DNA vaccines: roles against diseases.Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device Fusion to the Lysosome Targeting Signal of the Invariant Chain Alters the Processing and Enhances the Immunogenicity of HIV-1 Reverse Transcriptase Therapeutic and prophylactic DNA vaccines for HIV-1.DNA Immunization for HIV Vaccine Development.Nucleic acid vaccination strategies against infectious diseases.New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.Antibody production by in vivo RNA transfection.DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers.IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells

P2860

Q26740042-229E4CDE-A7C9-4867-BA9D-C05EBA479C6A Q26865388-CB75F722-E3B8-4EF1-83B4-4F47F126C08C Q27013314-AD620C36-98ED-48FD-BA73-44C1C71AB6C4 Q27316075-125E7880-BF22-43E8-9F9D-9B3E0662DDD8 Q30364312-E1DEE28F-CA5B-4887-A431-1731AA72AF91 Q30841376-A7C0D3FB-0CD5-4ED4-BECD-AD3219894C4A Q33847809-027F43D3-938A-44B5-B056-7D9F968E4A97 Q34250318-973CEDE4-370B-460E-973A-D1535973EF13 Q34369139-C33ECBAA-EE7B-4F4F-B437-F7FE51FE2EE1 Q35826688-C5E9629D-21BF-4199-A15D-D385030CF93A Q35826692-344BDC0D-DFAA-43BF-B53C-8A276604C15B Q35826742-C29E7DE7-4CD8-4FC2-A4D9-9F405B639699 Q35826747-55D42197-F26A-4075-85E1-B2F292E72309 Q36256319-58B35261-3E34-43B5-811B-B99B9C9A1ECE Q36256428-0FC2C2D3-1997-4EAB-8266-01BEE18BDB61 Q36257975-62630607-A02C-4E08-8B23-76F99675F476 Q36258203-13094A2A-A43E-43E8-90C8-B2BB93ED91AB Q36476095-B4F75835-00D8-474E-B3D6-D1948303B7B1 Q36637349-A0A04696-48E9-40BB-986D-F6917CF42DBD Q36668517-7D986684-7512-47BE-990F-7DAE486A08BC Q36694836-E96CEE9D-ED18-4F6A-BCD2-AA9E8707CAB5 Q36893661-552ACFBF-478B-4087-91F1-07812EF2BF87 Q37441566-369C9BEE-6C78-4CB1-9A8A-FE144781133C Q37530461-9116F246-EC26-4237-9EBB-4858F05B2EF9 Q37530466-20F1BF42-4AA0-4217-9B98-2FABF80E7168 Q37550619-687B6074-5D93-40B8-B5D3-9B35309826E8 Q37722979-A2EA410F-C894-4657-AF7C-7746E9AB51B7 Q38088037-6776BCD8-C4E2-405F-9F18-6C70FD0A0051 Q38581981-3142CA40-0180-40EE-8E55-29B82410C2F7 Q38586079-1FA663FB-CCCF-493C-B9D8-6C25544AADA4 Q38748193-3A14399D-1ECC-4395-B112-DD5EAC6F2485 Q40052131-ABA1245E-E8E9-4573-9152-E84DCA18AF24 Q47619072-F6DBD027-3551-4FFD-86AD-0D7555F9FE34 Q57117718-B21BE5CF-6FE7-4C05-81DA-D6F803DB4F3E

P2860

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

http://www.wikidata.org/entity/Q37996192

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

@en

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.

@nl

type

label

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

@en

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.

@nl

prefLabel

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

@en

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.

@nl

P1433

Q37996192-AC5E5CF9-AA1A-4340-8093-38DE18E7A74E

P1476

Q37996192-D09D7136-D04A-435A-A9BD-B6FE9B02172D

P2093

Q37996192-073E3AEC-66FE-4B63-9929-437DBFB023FB

Q37996192-2644251C-5C88-4774-9215-74F78B4F4145

Q37996192-265D11B1-CB1E-430F-885D-63FEEEAE6AB5

Q37996192-9900CAAF-963F-4691-AE08-ACD74179705A

Q37996192-CE54E075-A9AA-4208-A2DB-9BD7F7044D4F

P2860

Q37996192-0121EACB-B6CD-4F72-90B0-BB46CD490E42

Q37996192-0299C2F7-722E-4B4A-BAFA-78E7FBE7959D

Q37996192-03837417-4902-4B06-B1CB-51E55732E4F4

Q37996192-0B46E7BB-C8B3-4707-94CA-9C302750F66F

Q37996192-0D6EF202-18D9-4A2A-89C0-F141F9A64248

Q37996192-118E291E-252C-4369-A1B5-1DCE8C8FFFB5

Q37996192-17BAFE59-C8EB-412D-AD8F-485DC256E2B2

Q37996192-1E5050BA-3480-4A7B-9923-89760D109DBA

Q37996192-1E5FEB7F-F058-4B4A-A7FA-73997E5C03D3

Q37996192-213FF278-8E4C-4717-901B-F4A28459BC1F

P304

Q37996192-3903090C-9B28-4FFE-BEAA-85476A17BEA8

P31

Q37996192-F3AD3F63-5207-4825-95BB-3B7CBD78162C

P356

Q37996192-4388D1B3-CAA1-4DC3-B270-2E6A61B0865A

P433

Q37996192-BA61340F-2A68-42AA-AE45-48F095716CE4

P478

Q37996192-D154EC90-5618-42D0-9771-2A8A1E0B3EB7

P577

Q37996192-3647C0A7-D01B-492A-B0CA-780B3CA5DF2D

P5875

Q37996192-E068D9E5-EC5B-450A-9AB7-FAB80C414010

P698

Q37996192-419C527F-C2D6-4420-BC0C-B40C665C304F

P921

Q37996192-F75D165C-72B1-47C5-83CE-77A714C6241F

P932

Q37996192-08A413CC-CF5F-47E1-BA6C-5C20AD2FFE24

P356

J.COVIRO.2011.08.003

P1433

Current opinion in virology

P1476

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo

@en

P2093

Chaoran Billie Bian

http://www.w3.org/2001/XMLSchema#string

David B Weiner

http://www.w3.org/2001/XMLSchema#string

Devin J F Myles

http://www.w3.org/2001/XMLSchema#string

Karuppiah Muthumani

http://www.w3.org/2001/XMLSchema#string

Natalie A Hutnick

http://www.w3.org/2001/XMLSchema#string

P2860

Membrane electroporation: a molecular dynamics simulation.

Gene transfer into mouse lyoma cells by electroporation in high electric fields

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

The molecular basis of electroporation.

Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Microneedle-based vaccines

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.

Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.

P304

233-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.COVIRO.2011.08.003

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221969613

http://www.w3.org/2001/XMLSchema#string

P698

22440782

http://www.w3.org/2001/XMLSchema#string

P921

P932

3725312

http://www.w3.org/2001/XMLSchema#string